| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.001 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.15 | 0.001 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.096 | 0.001 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | 0.098 | 0.002 |
| mRNA | OSI-027 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | Pazopanib | GDSC1000 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | -0.094 | 0.003 |